Skip to main content
Clinical Trials/ISRCTN18167626
ISRCTN18167626
Completed
Not Applicable

Treatment of early stage osteonecrosis of the femoral head with implantation of autologous bone marrow-derived and cultured mesenchymal stem cells: a single centre randomised controlled interventional trial

Dalian University Zhongshan Hospital (China)0 sites100 target enrollmentFebruary 9, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteonecrosis of the femoral head at early stage
Sponsor
Dalian University Zhongshan Hospital (China)
Enrollment
100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 9, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dalian University Zhongshan Hospital (China)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged between 18 to 45 years, either sex
  • 2\. Patients with hips at stages IC to IIC according to Association Research Circulation Osseous (ARCO) classification
  • 3\. Etiological factors including trauma, alcohol abuse, corticosteroid use, Caisson disease, hyperlipidemia, and idiopathic

Exclusion Criteria

  • 1\. Pregnancy
  • 2\. Current and previous infection
  • 3\. Skeletal immaturity
  • 4\. Immunosuppressive drug therapy
  • 5\. A history of inflammatory arthritis
  • 6\. Evidence of cardiovascular diseases
  • 7\. Prior systemic corticosteroid treatment
  • 8\. Mental health problems preventing adequate follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials